Humoral and cellular immune response induced by rVSV Delta G-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea

摘要

Background: As part of a Phase III trial with the Ebola vaccine rVSV Delta G-ZEBOV-GP in Guinea, we invited frontline workers (FLWs) to participate in a sub-study to provide additional information on the immunogenicity of the vaccine.